Get Premium to unlock powerful stock data
NAS:ERAS (USA)  
Erasca Inc logo

Erasca Inc

$ 5.41 -0.2 (-3.57%) 08:08 PM EST
P/E:
At Loss
P/B:
1.56
Market Cap:
$ 659.25M
Enterprise V:
$ 320.52M
Volume:
258.04K
Avg Vol (2M):
487.99K
Volume:
258.04K
Market Cap $:
659.25M
PE Ratio:
At Loss
Avg Vol (2-Month):
487.99K
Enterprise Value $:
320.52M
PB Ratio:
1.56
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Erasca Inc
NAICS : 541714 SIC : 2834
10835 Road to the Cure, Suite 140, San Diego, CA, USA, 92121
Description
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers.
Name Current Vs Industry Vs History
Cash-To-Debt 13.34
Equity-to-Asset 0.89
Debt-to-Equity 0.07
Debt-to-EBITDA -0.26
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.02
9-Day RSI 55.91
14-Day RSI 50.59
6-1 Month Momentum % -61.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.86
Quick Ratio 18.86
Cash Ratio 18.35

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -65.08
ROA % -36.51
ROIC % -234.32
ROC (Joel Greenblatt) % -542.27
ROCE % -31.33

Financials (Next Earnings Date:2022-08-26 Est.)

ERAS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ERAS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.276
Beta 0
Volatility % 0
14-Day RSI 50.59
14-Day ATR ($) 0.454271
20-Day SMA ($) 5.2895
12-1 Month Momentum % 0
52-Week Range ($) 4.51 - 24.47
Shares Outstanding (Mil) 121.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Erasca Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More